Greenwich LifeSciences
GLSI • NASDAQ
Greenwich LifeSciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Snehal S. Patel, with a market cap of $349.0M.
CEOSnehal S. Patel
Market Cap$349.0M
Biotechnology
Healthcare
Employees6.0
Websitegreenwichlifesciences.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Greenwich LifeSciences
Date
Tuesday, April 14, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.32
Earnings History
Past 12 earnings reports for Greenwich LifeSciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.30Est: -$0.32 | +6.3% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.30Est: -$0.23 | -30.4% | - | — | 10-Q |
| May 20, 2025 | Q1 2025 | -$0.25 | — | - | — | 10-Q |
| Apr 15, 2025 | Q4 2024 | -$0.61 | — | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.20Est: -$0.21 | +4.8% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.20 | — | - | — | 10-Q |
| May 20, 2024 | Q1 2024 | -$0.19Est: -$0.20 | +5.0% | - | — | 10-Q |
| Apr 15, 2024 | Q4 2023 | -$0.21Est: -$0.20 | -5.0% | - | — | 10-K |
| Oct 19, 2023 | Q3 2023 | -$0.19 | — | - | — | 10-Q |
| Aug 21, 2023 | Q2 2023 | -$0.13Est: -$0.23 | +43.5% | - | — | 10-Q |
| May 22, 2023 | Q1 2023 | -$0.17Est: -$0.23 | +26.1% | - | — | — |
| Mar 31, 2023 | Q4 2022 | -$0.22Est: -$0.18 | -22.2% | - | — | — |